Joseph Kim, MD, on the utility of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma.
Joseph Kim, MD
Advertisement
Articles by Joseph Kim, MD
Joseph Kim, MD, discusses the multidisciplinary management of hepatocellular carcinoma.
Joseph Kim, MD, discusses the evolution of therapy in metastatic hepatocellular carcinoma.
Joseph Kim, MD, discusses curative therapeutic options in hepatocellular carcinoma.
Advertisement
Latest Updated Articles
Dr. Kim on the Utility of Atezolizumab/Bevacizumab in HCCPublished: December 21st 2020 | Updated:
Dr. Kim on the Multidisciplinary Management of HCCPublished: December 15th 2020 | Updated:
Dr. Kim on the Evolution of Therapy in Metastatic HCCPublished: December 1st 2020 | Updated:
Dr. Kim on Curative Treatment Options in HCCPublished: November 25th 2020 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma
2
Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer
3
Anti–Gremlin-1 Therapy Plus Chemo Makes Waves in GI Malignancies
4
FDA Grants Fast Track Designation to IBI3003 in Relapsed/Refractory Multiple Myeloma
5